We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Biopharma Credit Plc | LSE:BPCR | London | Ordinary Share | GB00BDGKMY29 | ORD USD0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.876 | 0.876 | 0.878 | 0.878 | 0.874 | 0.874 | 455,161 | 14:13:46 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 135.74M | 108.45M | 0.0833 | 10.56 | 1.15B |
TIDMBPCR
RNS Number : 8611B
BioPharma Credit PLC
06 April 2017
BioPharma Credit PLC (the "Company")
Correction: Total Voting Rights
6 April 2017
The following amendment has been made to the 'Total Voting Rights' announcement released on 3 April 2017 at 15:00 under RNS No 4049B:
"Ordinary $0.01 shares" not "Ordinary $1.00 shares".
This was also incorrect in the following announcements: RNS No 7414A, RNS No 7415A, RNS No 7420A, RNS No 8749A, RNS No 0439B, RNS No 1995B, RNS No 2073B, RNS No 7065B, RNS No 7191B.
All other details remain unchanged.
The full amended text is shown below.
In conformity with the provisions of the FCA's Disclosure Guidance and Transparency Rules, the Company notifies the market that the issued share capital and voting rights of the Company, as at 31 March 2017, were as follows:
Class of Total number Number Total number Number of Total number share of shares in of voting of voting shares held of shares circulation rights rights of in treasury in issue attached shares in (carrying to each circulation no voting share rights attached until issued) --------------- -------------- ----------- ------------- ----------------- ------------- Ordinary $0.01 shares 761,877,360 1 761,877,360 0 761,877,360 --------------- -------------- ----------- ------------- ----------------- -------------
The above total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in BioPharma Credit PLC under the FCA's Disclosure Guidance and Transparency Rules.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRUNONRBOASRAR
(END) Dow Jones Newswires
April 06, 2017 13:00 ET (17:00 GMT)
1 Year Biopharma Credit Chart |
1 Month Biopharma Credit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions